Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147

In the randomized phase III trial N0147 for resected colon cancer, the early trial versions included treatment arms of FOLFIRI (irinotecan, 5-fluorouracil, and leucovorin) with and without cetuximab, in addition to FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin) with and without cetuximab. In t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Huang, Jocelin, Nair, Suresh G., Mahoney, Michelle R., Nelson, Garth D., Shields, Anthony F., Chan, Emily, Goldberg, Richard M., Gill, Sharlene, Kahlenberg, Morton S., Quesenberry, James T., Thibodeau, Stephen N., Smyrk, Thomas C., Grothey, Axel, Sinicrope, Frank A., Webb, Thomas A., Farr, Gist H., Pockaj, Barbara A., Berenberg, Jeffrey L., Mooney, Margaret, Sargent, Daniel J., Alberts, Steven R.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4019685/
https://ncbi.nlm.nih.gov/pubmed/24512953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2013.12.002
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia